Test Price
650 AED✅ Home Collection Available
Hepatitis C Virus (HCV) Qualitative PCR Test in UAE | 650 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
Executive Summary — The HCV Qualitative PCR is a molecular diagnostic assay that detects viral RNA in blood, confirming active hepatitis C infection with 99.9% diagnostic sensitivity. This gold-standard test is essential for early diagnosis, treatment monitoring, and sustained virologic response assessment. Processing is performed in an ISO 9001:2015 accredited laboratory (Cert: INT/EGQ/2509DA/3139) under strict quality controls.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance with our DHA-licensed physicians.
- Insurance & Support: Direct Billing Verification via WhatsApp +971 54 548 8731 – instant confirmation.
Test Overview & Methodology
The Hepatitis C Virus (HCV) Qualitative PCR is a molecular diagnostic assay that detects viral RNA in peripheral blood, confirming active infection with near-absolute certainty. Using real-time polymerase chain reaction (qPCR) technology, the test amplifies and identifies the genetic material of the virus, enabling diagnosis within 1–2 weeks post-exposure. It is the gold standard for diagnosing acute and chronic hepatitis C in at-risk populations and for monitoring antiviral treatment response. Results guide clinical decisions regarding direct-acting antiviral (DAA) therapy and sustained virologic response assessment.
| Feature | Our Test (Real-Time PCR + WGS) | Closest Alternative (Anti-HCV Rapid/ELISA) |
|---|---|---|
| Methodology | Real-Time PCR (qPCR) with Whole Genome Sequencing (WGS) confirmation | Immunoassay for antibodies (serology) |
| Target | HCV-RNA (direct viral presence) | Anti-HCV IgG/IgM (host immune response) |
| Sensitivity / Specificity | >99% / near 100% | 95-98% / may cross-react |
| Window Period | Detects RNA as early as 1-2 weeks post-exposure | Seroconversion takes 4-10 weeks, missing early infection |
| Turnaround Time | 2-3 days | Rapid test: 20 min; ELISA: 1-2 days |
| Clinical Utility | Diagnosis of active infection, treatment monitoring | Screening only; requires PCR confirmation |
Physician Insight & Safety Protocols
“As a General Practitioner with extensive experience in primary care across the UAE, I consider the HCV Qualitative PCR test an indispensable tool for early detection of active hepatitis C infection. Direct detection of viral RNA allows clinicians to initiate timely antiviral therapy and prevent progression to chronic liver disease. A positive result must be correlated with liver function tests and imaging, and prompt referral to a hepatologist is strongly recommended for comprehensive fibrosis staging and treatment planning. Relying solely on PCR results without clinical context is never advisable.”
— Dr. Ajay Singh, DHA License No. 36234132
Medication Advisory
Do not discontinue any prescribed antiviral, immunosuppressive, or hepatoprotective medication prior to this test without consulting your treating physician. Abrupt cessation can trigger viral flare or hepatic decompensation. Always inform the phlebotomist about your current medication list, including over-the-counter supplements.
Safety Exclusion Criteria & Emergency Red Flags
⚠ Home Collection Exclusion
- Acute febrile illness (temperature >38.5°C) within 24 hours
- Severe coagulopathy (INR >1.5) without medical clearance
- Active bleeding or petechiae
- Patient unable to provide informed consent (confused/minor without guardian)
⚠ Seek Emergency Care Immediately
- Sudden onset of jaundice or scleral icterus
- Confusion, flapping tremor (hepatic encephalopathy)
- Severe abdominal distension or coffee-ground vomiting
- Vomiting blood or passing black tarry stools
Patient FAQ & Clinical Guidance
1. What is the Hepatitis C Virus (HCV) Qualitative PCR test and how does it work?
This test detects hepatitis C viral RNA in blood, confirming active infection with high accuracy. It uses real-time polymerase chain reaction (qPCR) technology to amplify and identify the genetic material of the virus. Unlike antibody tests, it directly demonstrates viral presence, enabling diagnosis within 1–2 weeks from exposure. Results are essential for initiating direct-acting antiviral (DAA) therapy and monitoring sustained virologic response. The test is performed on serum or plasma obtained from a standard blood draw.
2. Why is a doctor's prescription mandatory for this molecular diagnostic test?
Prescription is mandatory to contextualize results, ensuring immediate linkage to a hepatologist for any positive finding. UAE regulations (Federal Decree-Law No. 4 of 2016 on Medical Liability) mandate physician oversight for molecular diagnostics to guarantee proper pre-test counseling, accurate sample collection, and post-test follow-up. This safeguards you from misinterpretation and unnecessary anxiety, and ensures that results are integrated into a comprehensive care plan.
3. How should I prepare for the blood sample collection?
Fasting is not necessary, but refrain from fatty meals and alcohol for 24 hours beforehand. Adequate hydration improves venous access. Inform the phlebotomist if you are on anticoagulant therapy. There are no activity restrictions; however, we recommend avoiding strenuous exercise 2 hours prior. Wear loose-fitting clothing to facilitate arm access. If you experience dizziness or anxiety related to blood draws, inform the phlebotomist so they can accommodate you accordingly.
UAE Regulatory & Data Privacy Adherence
Data Protection & Clinical Compliance Framework
All laboratory procedures and patient data handling comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. These regulations mandate strict confidentiality, secure electronic health records, and patient consent protocols for all diagnostic data. Additionally, clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring that all molecular diagnostics are performed under appropriate physician oversight and with full informed consent. Our laboratory is licensed by the Dubai Health Authority (DHA) and operates under ISO 9001:2015 quality management standards (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Hepatitis C Virus (HCV) Qualitative PCR |
| Price (AED) | 650 |
| Turnaround Time | 2-3 Business Days |
| Sample Type / Matrix | Peripheral Blood (Serum or Plasma) |
| Methodology Used | Real-Time Polymerase Chain Reaction (qPCR) |
| ICD-10-CM Code | B17.1 |
| LOINC Code | 20416-4 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians